Impel Pharmaceuticals is focused on developing and providing transformative therapies for people suffering from diseases with high unmet needs across various disease areas in addition to the central nervous system (CNS), through the pioneering of an optimized approach to drug delivery. We offer and develop treatments that pair the Company’s proprietary Precision Olfactory Delivery (POD®) technology with well-established therapeutics.
Company Details
- Employees
- 48
- Founded
- -
- Address
- 1772 Keller Pkwy,
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://impelpharma.com
- HQ
- Keller, Texas
Impel Pharmaceuticals Questions
Impel Pharmaceuticals's website is http://impelpharma.com
Impel Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/impel-pharma
Impel Pharmaceuticals has
48 employees.
View email and phone details for 48
employees at Impel Pharmaceuticals.
Impel Pharmaceuticals's industry is
Pharmaceutical Manufacturing
Impel Pharmaceuticals's top competitors are
Junevity,
Ardelyx, Inc.,
Calliditas Therapeutics,
Lundbeck,
Eversana,
Axsome Therapeutics, Inc.,
Madrigal Pharmaceuticals,
Sage Therapeutics,
Merz Therapeutics,
Phathom Pharmaceuticals.
Impel Pharmaceuticals's categories are Pharmaceutical Manufacturing
Impel Pharmaceuticals's founding year is 2008
